As AI agents expose the limitations of static access controls, CrowdStrike advances open standards sharing real-time security signals for risk-aware enforcement at industry scale CrowdStrike (NASDAQ: ...

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced it has joined both the OpenID Foundation as a Sustaining Corporate Member, the highest level of membership, and IDPro to ...

The Marvel Cinematic Universe is “back to phase zero” with the release of Avengers: Doomsday, co-director Joe Russo has said. Speaking at SXSW, attended by The Hollywood Reporter, Russo told fans to ...

The modern pharmaceutical landscape is undergoing rapid transformation. Whether dealing with small molecules, complex biologics, or hybrid modalities, active pharmaceutical ingredient (API) ...

Shift says a ‘magic hat’ will record its cleaners working inside your home. Shift says a ‘magic hat’ will record its cleaners working inside your home. is a London-based reporter at The Verge ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Fujio Mitarai, Chairman and CEO of Canon Inc. From imaging and healthcare to advanced ...

The oceans cover more than 70% of the earth’s surface area and contain extremely rich natural resources, which could effectively solve human’ s energy shortage problem [1] [2]; Besides, the oceans ...

Figure 1: Schematic of two-photon polymerization direct laser writing inside a liquid crystal director. Localized polymerization forms a rigid network that locks the liquid crystal director and ...

Stellar Blade developer SHIFT UP has fully acquired UNBOUND, the Tokyo-based game studio founded by Resident Evil creator and Devil May Cry producer Shinji Mikami in November 2022, the company ...

Abstract: Pulse density modulation (PDM) can reduce switching losses by achieving zero voltage switching (ZVS) and zero current switching (ZCS), enabling high-efficiency operation of resonant ...

3-weekly docetaxel 75 mg/m2 vs 2-weekly docetaxel 50 mg/m2 in combination with darolutamide + ADT in patients with mHSPC: Subgroup analyses from the randomised phase 3 ARASAFE trial. This is an ASCO ...